Home> Products> anticholinergic agent

{ "products": [ { "_id": "6a4cf32ff4503514c0b03999", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "tropicamide eye drops ip", "description": "Tropicamide eye drops IP are a prescription ophthalmic solution used to dilate the pupil (mydriasis) and temporarily paralyze the eye's focusing muscles (cycloplegia) before eye examinations and certain ocular procedures. Dilation typically begins within 20–40 minutes of application and lasts around 4–6 hours, though effects can occasionally persist longer. Tropicamide is widely used by ophthalmologists and optometrists to get a clear, detailed view of the retina, optic nerve, and back of the eye — something that isn't possible through an undilated pupil. It's generally well tolerated, though temporary blurred vision and light sensitivity are expected effects rather than side effects to worry about.\nWhat Is Tropicamide Eye Drops IP?\nTropicamide eye drops IP (manufactured to Indian Pharmacopoeia standards) are an anticholinergic (antimuscarinic) ophthalmic solution, commonly available in 0.5% and 1% strengths. “IP” indicates the formulation meets the quality and purity standards set by the Indian Pharmacopoeia.\nTropicamide belongs to the same broad drug family as atropine but has a much shorter duration of action, which is precisely why it's the preferred choice for routine eye examinations — it does its job quickly and wears off within hours rather than days. It's typically administered directly by a healthcare provider in a clinical or hospital setting, rather than self-administered at home.\nHow Tropicamide Works (Mechanism of Action)\n\nMuscarinic receptor blockade — Tropicamide blocks acetylcholine from binding to muscarinic receptors in the eye's iris sphincter and ciliary muscles.\nPupil dilation (mydriasis) — With the sphincter muscle relaxed, the pupil's natural constricting reflex is blocked, allowing it to widen.\nParalysis of accommodation (cycloplegia) — The ciliary muscle, responsible for adjusting eye focus for near vision, is also relaxed, temporarily reducing the eye's ability to focus on close objects.\nClear visualization of the fundus — With the pupil fully dilated, the examining doctor can clearly view the retina, macula, optic nerve, and vitreous — structures that are otherwise obscured behind an undilated pupil.\nNatural wearing-off — As the drug is metabolized and clears from the eye tissue, muscle tone gradually returns, and the pupil returns to its normal size and reactivity.\n\nClinical Indications\nUse CaseWhy Tropicamide Is UsedDilated fundus examinationAllows a detailed view of the retina, optic nerve, and maculaPre- and post-cataract surgeryAchieves adequate pupil dilation for surgical visibility and reduces post-operative inflammation-related discomfortDiagnosis of refractive errors in childrenCycloplegic effect prevents the eye from actively focusing, giving a more accurate refraction measurementRetinal and posterior segment proceduresSupports clear visualization for laser treatments and retinal surgeryEvaluation of optic nerve or cranial nerve abnormalitiesHelps assess disc swelling, cup-to-disc ratio, and pupillary responsesAnterior uveitis management (adjunctive use)Cycloplegic effect can reduce pain and the risk of complications like posterior synechiae\nDosage Guidelines\nParameterTypical GuidanceStandard strength0.5% or 1% ophthalmic solutionTypical doseOne drop instilled into the eye(s), as directed by the examining doctorOnset of actionDilation usually begins within 20–40 minutesDuration of effectCommonly 4–6 hours; can occasionally last longer depending on individual responseAdministration techniqueTilt the head back, pull down the lower eyelid, instill the drop, then close the eye gently for 2–3 minutes without blinking; applying gentle pressure at the inner corner of the eye can help limit systemic absorptionRepeat dosingA second drop may be used after several minutes if dilation is insufficient, at the doctor's discretion\nTropicamide is typically administered by a healthcare professional in a clinical setting rather than self-instilled at home, and dosing should always follow the specific instructions of the treating doctor.\nKey Benefits\n\nProvides fast, reliable pupil dilation, enabling a thorough examination of the back of the eye\nShort duration of action (compared to atropine) means vision and eye function return to normal within hours, not days\nWell-established, widely used mydriatic with a strong long-term safety record in clinical practice\nSupports more accurate diagnosis of refractive errors in children through its cycloplegic effect\nUseful both for routine diagnostic eye exams and as part of pre-/post-surgical eye care\nAvailable in two strengths (0.5% and 1%), allowing the examining doctor to tailor the degree of dilation needed\n\nPrecautions\n\nShould only be administered by, or under the direct guidance of, a qualified eye care professional\nWear sunglasses after application, since dilated pupils let in significantly more light and cause noticeable light sensitivity\nAvoid driving or operating machinery until vision returns to normal, as focusing on nearby objects (like a dashboard or phone) will be impaired\nDo not wear contact lenses during instillation, as the preservative in some formulations can discolor soft lenses\nUse caution in patients with a history of narrow-angle glaucoma, as pupil dilation can rarely trigger a sudden, serious rise in eye pressure (angle-closure glaucoma)\nIn children, wash hands thoroughly after administration, since rare but serious anticholinergic effects (including psychosis) have been reported, particularly with higher doses or accidental ingestion\nInform the doctor of any history of heart conditions, as anticholinergic effects can occasionally affect heart rate\n\nSide Effects\nCommon side effects (expected and temporary):\n\nBlurred vision, especially for near objects\nIncreased sensitivity to light (photophobia)\nMild stinging or burning sensation on application\nTransient increase in intraocular pressure\n\nLess common side effects:\n\nDry mouth\nHeadache\nIncreased heart rate\nFlushing or mild fever\nEye surface irritation\n\nRare but serious side effects — seek immediate medical attention:\n\nSigns of an allergic reaction: hives, difficulty breathing, swelling of the face, lips, tongue, or throat\nConfusion, slurred speech, agitation, or hallucinations (rare anticholinergic toxicity, more often reported in children)\nSudden eye pain, severe headache, nausea, or vomiting (possible signs of angle-closure glaucoma)\n\nMost side effects resolve on their own as the drug wears off within a few hours; however, any signs of a serious reaction should be reported to a doctor right away.\nComparison with Alternatives\nFeatureTropicamideAtropineOnset of action20–40 minutes30–40 minutesDuration of effect4–6 hours (short-acting)Up to 1–2 weeks (long-acting)Common useRoutine diagnostic dilation, fundus examsCycloplegic refraction in select cases, anterior uveitis managementPreferred settingOutpatient eye exams, same-day proceduresCases needing prolonged cycloplegia\nTropicamide's shorter duration makes it the preferred first choice for most routine eye examinations, where rapid return to normal vision is desirable.\nKey Statistics\n[Placeholder — pending clinical/regulatory team verification. Do not publish without confirmed source citation for dilation success rates, comparative onset/duration data, or incidence rates of rare adverse effects.]\nExpert Insight\n[Placeholder — reserved for a quote from a qualified ophthalmologist or clinical reviewer. Do not publish without a verified, attributable expert quote.]\nFrequently Asked Questions\n1. What is tropicamide eye drops used for?\nTropicamide eye drops are used to dilate the pupil and temporarily relax the eye's focusing muscles, allowing an eye doctor to clearly examine the retina, optic nerve, and back of the eye during routine eye exams and certain procedures.\n2. How long does dilation last with tropicamide?\nDilation typically begins within 20–40 minutes and lasts about 4–6 hours, though this can vary slightly from person to person. Vision usually returns to normal well within the same day.\n3. What are the risks of tropicamide eye drops?\nCommon effects include temporary blurred vision and light sensitivity. Less commonly, dry mouth, headache, or a faster heartbeat can occur. Rare but serious risks include an allergic reaction or, in susceptible individuals, a sudden rise in eye pressure (angle-closure glaucoma) — these require immediate medical attention.\n4. What are the benefits of tropicamide?\nTropicamide allows for fast, reliable pupil dilation with a much shorter recovery time than older agents like atropine, enabling accurate diagnosis of retinal and optic nerve conditions while letting patients return to normal vision within hours.\nConclusion\nTropicamide eye drops IP remain one of the most widely used and trusted tools in modern eye care, offering fast-acting, short-duration pupil dilation that allows eye care professionals to thoroughly examine the structures at the back of the eye. Its short window of action compared to older cycloplegic agents like atropine makes it especially well suited for routine diagnostic exams, where patients need their vision to return to normal within the same day. While temporary blurred vision and light sensitivity are expected parts of the experience, tropicamide has a strong long-term safety record when administered appropriately by a qualified eye care professional. As with any prescription ophthalmic agent, it should only be used under medical supervision, with simple precautions like wearing sunglasses afterward and avoiding driving until vision normalizes.\n\nDisclaimer: This content is for informational purposes only and is not a substitute for professional medical advice. Tropicamide eye drops IP are a prescription medicine and should only be administered by, or under the direct guidance of, a qualified eye care professional.\nManufactured by:\nSteris Healthcare Pvt. Ltd.\nWHO-GMP & ISO Certified Pharmaceutical Manufacturer\nEmail: contact@sterispharma.com | info@sterispharma.com\nContent last reviewed: July 2026", "price": 50.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2466, "imageuri": "https://productimages.withfloats.com/actual/6a4cf331dd4ec8cc0aa1b9e4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a4cf331dd4ec8cc0aa1b9e4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-07T12:38:07.8Z", "updatedon": "2026-07-07T12:38:07.8Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tropicamide-eye-drops-ip/2466", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION TRACOPA 1%", "category": "Opthalmology Range", "tags": [ "tropicamide eye drops ip", "tropicamide eye drops ip uses in hindi", "tropicamide eye drops", "tropicamide eye drops uses", "tropicamide eye drops uses in hindi", "tropicamide eye drops price", "tropicamide eye drops bottle", "tropicamide eye drops side effects", "tropicamide eye drops brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69942f823b20a66d9dcf9458", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "description": "GLYCOPRESS INDUS™ is a modern dual bronchodilator therapy formulated with Indacaterol Maleate and Glycopyrronium Bromide, designed for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD). This advanced inhalation formulation combines two complementary mechanisms of action to deliver sustained airway relaxation, improved lung function, and enhanced breathing comfort.\n\nCOPD is a progressive respiratory condition characterized by airflow limitation, chronic inflammation, and episodes of breathlessness. Effective management requires consistent bronchodilation to keep the airways open and reduce daily symptoms. GLYCOPRESS INDUS™ addresses this need through a once-daily maintenance approach that targets airway narrowing through dual pharmacological pathways.\n\nManufactured under strict quality standards, GLYCOPRESS INDUS™ ensures reliable dosing, stability, and optimal pulmonary delivery when used with the recommended inhalation device. It is intended for regular use and not for the treatment of sudden breathing emergencies.\n\nComposition and Mechanism of Action\n\nGLYCOPRESS INDUS™ combines two long-acting bronchodilators:\n\n1. Indacaterol Maleate (Long-Acting Beta2-Agonist – LABA)\n\nIndacaterol stimulates beta2-adrenergic receptors located in the smooth muscles of the airways. Activation of these receptors causes the muscles to relax, resulting in bronchodilation. This effect:\n\nReduces airway resistance\n\nImproves airflow\n\nDecreases breathlessness\n\nSupports 24-hour bronchodilation\n\nIndacaterol is known for its rapid onset and prolonged duration of action, making it effective for once-daily therapy.\n\n2. Glycopyrronium Bromide (Long-Acting Muscarinic Antagonist – LAMA)\n\nGlycopyrronium blocks muscarinic receptors in the bronchial smooth muscles. These receptors normally respond to acetylcholine, which causes airway constriction. By inhibiting this response, glycopyrronium:\n\nPrevents bronchospasm\n\nReduces airway tightening\n\nPromotes sustained airway relaxation\n\nDual-Action Advantage\n\nThe combination of LABA and LAMA in GLYCOPRESS INDUS™ provides enhanced bronchodilation compared to either agent alone. While indacaterol actively relaxes airway muscles, glycopyrronium prevents them from tightening. This complementary action ensures comprehensive and sustained airway management.\n\nIndications and Uses\n\nGLYCOPRESS INDUS™ is indicated for:\n\nMaintenance treatment of chronic obstructive pulmonary disease (COPD)\n\nChronic bronchitis management\n\nEmphysema management\n\nLong-term airflow limitation therapy\n\nIt is important to understand that GLYCOPRESS INDUS™:\n\nIs not a rescue inhaler\n\nShould not be used for sudden acute bronchospasm\n\nIs not intended for primary asthma treatment unless prescribed by a physician\n\nPatients should always keep a short-acting bronchodilator available for emergency relief.\n\nKey Benefits of GLYCOPRESS INDUS™\n1. Once-Daily Dosing Convenience\n\nGLYCOPRESS INDUS™ is formulated for once-daily administration, improving adherence and simplifying treatment routines.\n\n2. Dual Bronchodilation for Superior Airway Control\n\nThe LABA + LAMA combination provides broader and more effective airway relaxation compared to single-agent therapy.\n\n3. Rapid Onset with Sustained Effect\n\nIndacaterol provides quick bronchodilation, while glycopyrronium maintains airway openness for up to 24 hours.\n\n4. Improved Lung Function\n\nRegular use can enhance lung performance parameters, such as improved airflow measurements and reduced air trapping.\n\n5. Reduced Breathlessness\n\nPatients may experience decreased shortness of breath during physical activities, leading to greater independence.\n\n6. Lower Frequency of COPD Exacerbations\n\nConsistent airway maintenance can help reduce the likelihood of flare-ups and hospital visits.\n\n7. Enhanced Quality of Life\n\nBetter breathing control contributes to improved sleep, increased exercise tolerance, and overall well-being.\n\nDosage and Administration\n\nGLYCOPRESS INDUS™ should be used exactly as prescribed by a healthcare professional.\n\nGeneral Administration Guidelines:\n\nUse once daily at the same time each day.\n\nInhale using the provided inhalation device.\n\nDo not swallow capsules (if capsule-based system).\n\nDo not exceed the recommended dose.\n\nFollow inhaler technique instructions carefully.\n\nProper inhalation technique is essential for effective drug delivery. Healthcare providers should demonstrate correct usage during initial prescription.\n\nPossible Side Effects\n\nWhile GLYCOPRESS INDUS™ is generally well tolerated, some individuals may experience side effects.\n\nCommon Side Effects\n\nDry mouth\n\nCough\n\nThroat irritation\n\nHeadache\n\nNasal congestion\n\nMild tremor\n\nDizziness\n\nThese symptoms are often mild and may diminish with continued use.\n\nCardiovascular Effects\n\nDue to the beta2-agonist component (indacaterol), some patients may experience:\n\nIncreased heart rate\n\nPalpitations\n\nMild fluctuations in blood pressure\n\nPatients with pre-existing heart conditions should consult their physician before starting therapy.\n\nAnticholinergic Effects (from Glycopyrronium)\n\nDifficulty urinating\n\nBlurred vision\n\nWorsening of narrow-angle glaucoma\n\nIndividuals with urinary retention or glaucoma should use caution.\n\nRare but Serious Reactions\n\nParadoxical bronchospasm (worsening breathing immediately after inhalation)\n\nSevere allergic reactions\n\nSignificant cardiac rhythm disturbances\n\nImmediate medical attention should be sought if severe reactions occur.\n\nPrecautions and Warnings\n\nBefore starting GLYCOPRESS INDUS™, inform your healthcare provider if you have:\n\nCardiovascular disease\n\nArrhythmias\n\nHypertension\n\nHyperthyroidism\n\nDiabetes\n\nSeizure disorders\n\nGlaucoma\n\nProstate enlargement\n\nKidney impairment\n\nDrug Interactions\n\nCaution is required when using:\n\nOther long-acting beta2-agonists\n\nOther anticholinergic medications\n\nBeta-blockers\n\nDiuretics\n\nCertain antidepressants (e.g., MAO inhibitors)\n\nAlways provide a complete list of medications and supplements to your healthcare provider.\n\nWho Should Use GLYCOPRESS INDUS™?\n\nGLYCOPRESS INDUS™ is ideal for:\n\nAdults with moderate to severe COPD\n\nPatients not adequately controlled on single bronchodilator therapy\n\nIndividuals seeking a once-daily maintenance inhaler\n\nPatients requiring dual bronchodilation for improved symptom control\n\nIt is not typically recommended for pediatric patients unless specifically directed by a healthcare professional.\n\nIntegrating GLYCOPRESS INDUS™ into COPD Management\n\nFor optimal results, GLYCOPRESS INDUS™ should be part of a comprehensive COPD management plan that includes:\n\nSmoking cessation\n\nPulmonary rehabilitation programs\n\nRegular physical activity\n\nBalanced nutrition\n\nScheduled medical follow-ups\n\nAdherence to therapy and routine monitoring significantly improve long-term outcomes.\n\nStorage Instructions\n\nStore at room temperature\n\nProtect from moisture and direct sunlight\n\nKeep in original packaging until use\n\nKeep out of reach of children\nConclusion\nGLYCOPRESS INDUS™ (Indacaterol Maleate + Glycopyrronium Bromide) is a powerful dual bronchodilator designed to provide sustained airway control in individuals living with chronic obstructive pulmonary disease. By combining a long-acting beta2-agonist and a long-acting muscarinic antagonist, it offers comprehensive bronchodilation through two complementary pathways.", "price": 703.0, "discountamount": 211.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2308, "imageuri": "https://productimages.withfloats.com/actual/69942f8410196f5f212c916f.png", "tileimageuri": "https://productimages.withfloats.com/tile/69942f8410196f5f212c916f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-17T09:06:10.4Z", "updatedon": "2026-04-08T08:59:59.008Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//fdc-of-indacaterol-maleate-and-glycopyrronium-bromide-inhalation-powder/2308", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLYCOPRESS INDUS", "category": "ASTHMARANGE", "tags": [ "indacaterol maleate", "fdc of indacaterol maleate uses", "fdc of indacaterol maleate uses in hindi", "fdc of indacaterol maleate and glycopyrronium bromide inhalation powder", "indacaterol maleate and glycopyrronium bromide", "indacaterol maleate glycopyrronium bromide price", "fdc of indacaterol maleate" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6960c83f3056ad8a5a1aecba", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Cinnarizine and Domperidone Tablets ", "description": "CLANARIZINE DOM represents an advanced pharmaceutical combination that brings together two potent therapeutic agents—Cinnarizine and Domperidone—in a single convenient tablet formulation. This innovative combination medication addresses multiple aspects of vestibular disorders, motion sickness, and associated nausea and vomiting, providing comprehensive relief for patients suffering from these debilitating conditions. Manufactured under stringent quality control standards, CLANARIZINE DOM offers a synergistic approach to managing symptoms that significantly impact quality of life and daily functioning.The combination of Cinnarizine and Domperidone in CLANARIZINE DOM is based on sound pharmacological principles. While Cinnarizine works primarily on the vestibular system to reduce dizziness and vertigo, Domperidone acts as an effective antiemetic to control nausea and vomiting. Together, these two active ingredients provide more comprehensive symptom control than either agent alone, making CLANARIZINE DOM an excellent choice for patients experiencing vestibular disturbances accompanied by gastrointestinal symptoms.This combination therapy is particularly valuable because vertigo, dizziness, and motion sickness are frequently accompanied by nausea and vomiting. Patients suffering from these conditions often find that addressing only one aspect of their symptoms provides insufficient relief. CLANARIZINE DOM's dual-action formula tackles both the underlying vestibular dysfunction and the accompanying gastrointestinal distress, offering patients a more complete therapeutic solution that improves both comfort and functional capacity.Understanding the Active IngredientsCinnarizine is a calcium channel blocker with specific antihistaminic and vestibular suppressant properties. Unlike systemic calcium channel blockers used for cardiovascular conditions, Cinnarizine selectively acts on the blood vessels in the inner ear and brain, improving blood flow to these areas. This enhanced circulation helps reduce the frequency and severity of vertigo attacks while also preventing motion sickness. Cinnarizine also possesses mild antihistaminic effects that contribute to its anti-nausea properties, though this is not its primary mechanism of action.The medication works by blocking calcium channels in the vestibular system, which helps stabilize the sensory organs responsible for balance. By reducing the excessive stimulation of the vestibular apparatus, Cinnarizine decreases the sensation of spinning or imbalance that characterizes vertigo. Additionally, its vasodilatory effects improve microcirculation in the inner ear, which can be beneficial for conditions where reduced blood flow contributes to symptoms.Domperidone is a peripheral dopamine antagonist that acts primarily as a prokinetic and antiemetic agent. Unlike some antiemetic medications that cross the blood-brain barrier and cause sedation or extrapyramidal side effects, Domperidone works predominantly in the peripheral nervous system. It blocks dopamine receptors in the chemoreceptor trigger zone (CTZ) located outside the blood-brain barrier, effectively preventing nausea and vomiting without causing significant central nervous system effects.Domperidone also enhances gastrointestinal motility by promoting coordinated contractions of the stomach and upper small intestine. This prokinetic effect helps empty the stomach more efficiently, reducing feelings of fullness, bloating, and discomfort that often accompany vestibular disorders. By accelerating gastric emptying, Domperidone also reduces the likelihood of gastroesophageal reflux, which can exacerbate nausea in some patients.The combination of these two medications in CLANARIZINE DOM creates a complementary therapeutic effect. While Cinnarizine addresses the vestibular component of dizziness and vertigo, Domperidone manages the gastrointestinal symptoms that frequently accompany these conditions. This dual approach provides more comprehensive symptom relief and improves overall treatment outcomes compared to monotherapy with either agent alone.Clinical Applications and UsesCLANARIZINE DOM is indicated for a wide range of conditions characterized by vertigo, dizziness, and associated nausea. Understanding these clinical applications helps healthcare providers select appropriate candidates for this combination therapy.Vestibular Disorders: The primary indication for CLANARIZINE DOM includes various vestibular disorders that cause vertigo and imbalance. These conditions include Ménière's disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis. Patients with these disorders experience episodes of spinning sensation, loss of balance, and often severe nausea. CLANARIZINE DOM helps reduce the frequency and intensity of vertigo attacks while controlling the accompanying gastrointestinal symptoms.Motion Sickness: CLANARIZINE DOM is highly effective for preventing and treating motion sickness, whether related to travel by car, boat, airplane, or amusement park rides. The medication can be taken prophylactically before travel or at the onset of symptoms. The combination is particularly useful for individuals who experience severe nausea and vomiting with motion sickness, as Domperidone provides powerful antiemetic effects that complement Cinnarizine's anti-motion-sickness properties.Migraine-Associated Vertigo: Many patients with migraines experience vestibular symptoms, including dizziness, vertigo, and motion sensitivity, either during migraine attacks or as independent episodes. CLANARIZINE DOM can help manage these vestibular manifestations of migraine, reducing both the vertigo and the nausea that often accompany migraine headaches.Post-Concussion Syndrome: Following head injuries, some patients develop persistent dizziness, balance problems, and nausea as part of post-concussion syndrome. CLANARIZINE DOM may provide symptomatic relief for these patients during their recovery period, though it should be used as part of a comprehensive treatment approach that includes rest, gradual return to activities, and vestibular rehabilitation when appropriate.Cerebrovascular Insufficiency: In older adults with reduced blood flow to the brain, symptoms such as dizziness, vertigo, tinnitus (ringing in the ears), and cognitive difficulties may develop. Cinnarizine's vasodilatory properties can improve cerebral circulation, potentially reducing these symptoms. The addition of Domperidone helps manage any associated nausea.Radiation-Induced or Chemotherapy-Induced Nausea: While not a primary indication, some healthcare providers use CLANARIZINE DOM as adjunctive therapy for patients undergoing cancer treatment who experience both nausea and dizziness. Domperidone's strong antiemetic properties are particularly valuable in this context.Key Benefits of CLANARIZINE DOMThe unique combination of Cinnarizine and Domperidone in CLANARIZINE DOM offers numerous advantages that make it a preferred choice for managing vestibular disorders and associated symptoms.Comprehensive Symptom Control: The primary benefit of CLANARIZINE DOM is its ability to address multiple symptoms simultaneously. Rather than requiring patients to take separate medications for vertigo and nausea, this combination provides unified treatment in a single tablet. This comprehensive approach improves symptom control across the full spectrum of vestibular disorder manifestations, from the spinning sensation to the gastrointestinal distress that often accompanies it.Improved Patient Compliance: Taking multiple medications can be burdensome, particularly for patients who feel dizzy or nauseated. CLANARIZINE DOM simplifies the treatment regimen by combining two medications in one tablet, making it easier for patients to adhere to their prescribed therapy. Better compliance translates to better outcomes, as consistent medication use is essential for managing chronic vestibular conditions.Synergistic Therapeutic Effects: The combination of Cinnarizine and Domperidone creates synergistic effects that enhance overall efficacy. While Cinnarizine reduces vestibular stimulation and improves inner ear blood flow, Domperidone prevents nausea and promotes gastric emptying. This dual action addresses both the cause and consequences of vestibular dysfunction, providing more complete relief than either medication alone.Reduced Central Nervous System Side Effects: Because Domperidone works primarily in the peripheral nervous system rather than crossing the blood-brain barrier extensively, CLANARIZINE DOM causes less sedation and fewer cognitive effects compared to some alternative antiemetic medications. This allows patients to maintain better alertness and function during treatment, which is particularly important for those who need to continue working or performing daily activities.Enhanced Quality of Life: Vertigo and chronic dizziness significantly impair quality of life, limiting mobility, social interactions, and occupational functioning. The nausea and vomiting that accompany these conditions add another layer of disability. By effectively controlling both vestibular and gastrointestinal symptoms, CLANARIZINE DOM helps restore patients' ability to engage in normal activities, improving overall life satisfaction and functional independence.Fast Onset of Action: CLANARIZINE DOM provides relatively rapid symptom relief, with many patients experiencing improvement within 30 minutes to 2 hours after taking the medication. This quick onset is particularly valuable for acute episodes of vertigo or when taking the medication prophylactically before situations that might trigger motion sickness.Suitable for Long-Term Use: For patients with chronic vestibular disorders requiring ongoing treatment, CLANARIZINE DOM is generally safe for extended use when properly monitored by a healthcare provider. The medication maintains its effectiveness over time without significant tolerance development, making it suitable for long-term symptom management.Improved Gastric Emptying: The prokinetic effects of Domperidone benefit not only nausea but also other gastrointestinal symptoms such as early satiety, bloating, and upper abdominal discomfort. Patients with vestibular disorders often develop gastroparesis or delayed gastric emptying secondary to their condition, and Domperidone addresses this issue effectively.Vascular Benefits: Cinnarizine's ability to improve blood flow to the inner ear and brain provides additional benefits beyond symptom control. Enhanced microcirculation may support healing and recovery in conditions where vascular insufficiency contributes to vestibular dysfunction.Side Effects and Safety ConsiderationsLike all medications, CLANARIZINE DOM can cause side effects, though not everyone experiences them. Understanding potential adverse effects helps patients recognize when to seek medical attention and allows healthcare providers to monitor therapy appropriately.Common Side Effects:The most frequently reported side effect of CLANARIZINE DOM is drowsiness or sedation, occurring in approximately 10-20% of patients. This effect is primarily attributable to Cinnarizine's antihistaminic properties. Patients should avoid driving or operating machinery until they know how the medication affects them. Taking the medication at bedtime can minimize daytime drowsiness for some patients.Dry mouth is another common side effect, affecting roughly 10-15% of patients. This occurs due to anticholinergic effects and can be managed by sipping water frequently, chewing sugar-free gum, or using saliva substitutes if severe. Maintaining good oral hygiene is important to prevent dental problems associated with reduced saliva production.Mild gastrointestinal symptoms, including constipation, abdominal discomfort, or changes in bowel habits, may occur. While Domperidone promotes gastric emptying, it can occasionally alter bowel motility. These effects are usually mild and resolve with continued use or dose adjustment.", "price": 55.0, "discountamount": 17.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2271, "imageuri": "https://productimages.withfloats.com/actual/6960c8410b0da405bc908e58.png", "tileimageuri": "https://productimages.withfloats.com/tile/6960c8410b0da405bc908e58.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-01-09T09:19:59.281Z", "updatedon": "2026-03-12T09:24:10.244Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cinnarizine-and-domperidone-tablets-/2271", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CLANARIZINE DOM", "category": "NEUROLOGY RANGE", "tags": [ "cinnarizine and domperidone tablet uses", "what is cinnarizine & domperidone tablet used for", "cinnarizine domperidone combination medicine benefits", "how cinnarizine domperidone tablet works", "cinnarizine domperidone tablet for vertigo treatment", "cinnarizine domperidone tablet for inner ear problem", "cinnarizine domperidone tablet for balance disorder", "cinnarizine domperidone tablet for travel sickness", "cinnarizine domperidone tablet for gastric nausea", "cinnarizine & domperidone tablet price in india", "cinnarizine domperidone tablet brand name", "cinnarizine domperidone tablet manufacturer in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "690b41bfb84ade1a1a5cf07f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tiotropium Bromide and Formoterol Fumarate Inhaler", "description": "Tiotropium Bromide and Formoterol Fumarate Inhaler is a combination medication designed to provide long-term relief for patients suffering from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This inhaler combines the bronchodilator properties of tiotropium bromide with the fast-acting benefits of formoterol fumarate, ensuring both immediate and sustained relief from breathing difficulties. By improving airflow in the lungs, this inhaler significantly enhances the quality of life for individuals with obstructive airway diseases.\n\nComposition and Mechanism of Action\nThe inhaler contains two active ingredients:\n\nTiotropium Bromide – a long-acting anticholinergic agent that relaxes the muscles around the airways, preventing bronchospasm and helping to keep the airways open for an extended period.\n\nFormoterol Fumarate – a long-acting beta-2 adrenergic agonist (LABA) that quickly relaxes airway muscles, providing fast relief from shortness of breath and wheezing.\n\nTogether, these agents work synergistically. Tiotropium ensures long-term bronchodilation, while formoterol provides rapid symptom relief, making this inhaler ideal for patients who require both immediate and sustained respiratory support.\n\nUses\nThe Tiotropium Bromide and Formoterol Fumarate Inhaler is primarily used to:\n\nManage Chronic Obstructive Pulmonary Disease (COPD) – Helps reduce the frequency and severity of COPD exacerbations, improving breathing efficiency.\n\nControl Asthma Symptoms – Offers better control of persistent asthma symptoms, particularly in patients who do not respond adequately to standard inhalers.\n\nPrevent Exercise-Induced Bronchospasm – Can be used as part of a preventive regimen for patients prone to exercise-triggered breathing difficulties.\n\nEnhance Overall Lung Function – Improves airflow and oxygen exchange, contributing to better overall respiratory health.\n\nDosage and Administration\nProper usage of the inhaler is critical for maximum effectiveness. The dosage may vary based on your condition and doctor's recommendation. General guidelines include:\n\nTypically, one inhalation twice daily (morning and evening).\n\nShake the inhaler well before each use.\n\nExhale fully, place the mouthpiece in your mouth, and inhale deeply while pressing the inhaler to release the medication.\n\nHold your breath for 10 seconds after inhalation to ensure the medication reaches deep into the lungs.\n\nRinse your mouth with water after use to reduce the risk of oral infections or irritation.\n\nPatients should strictly follow their doctor’s instructions regarding dosage, frequency, and technique, as incorrect use may reduce the medication’s effectiveness.\n\nKey Benefits\n\nDual Action for Immediate and Long-Term Relief – Combines a fast-acting bronchodilator with a long-acting maintenance agent.\n\nReduces Exacerbations – Regular use can significantly lower the risk of flare-ups and hospital visits for COPD or severe asthma patients.\n\nImproves Lung Function – Enhances airflow and oxygen intake, leading to reduced shortness of breath and wheezing.\n\nConvenient Usage – A single inhaler provides both maintenance and symptom relief, reducing the need for multiple medications.\n\nEnhanced Quality of Life – Patients often experience better sleep, increased physical activity tolerance, and improved daily functioning.\n\nSide Effects\nWhile Tiotropium Bromide and Formoterol Fumarate Inhaler is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nDry mouth or throat irritation\n\nCough or hoarseness\n\nHeadache or dizziness\n\nTremors or mild palpitations\n\nSerious but rare side effects may include:\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nIrregular heartbeat or chest pain\n\nWorsening of respiratory symptoms\n\nPatients should immediately consult a healthcare professional if they experience severe or persistent side effects. Regular follow-up with a doctor is recommended to monitor lung function and adjust the dosage if necessary.\n\nPrecautions\n\nNot recommended for individuals with hypersensitivity to either tiotropium bromide or formoterol fumarate.\n\nShould be used cautiously in patients with cardiovascular diseases, kidney or liver problems, or thyroid disorders.\n\nAvoid sudden discontinuation without consulting your doctor, as this may worsen symptoms.\n\nAlways carry a rescue inhaler for emergency situations, as this inhaler is primarily for maintenance and not for immediate acute attacks.\n\nPrice\nThe price of Tiotropium Bromide and Formoterol Fumarate Inhaler may vary depending on the brand, pack size, and pharmacy. It is advisable to compare prices and check with local pharmacies for the most cost-effective options. Many insurance plans may cover this inhaler under prescription respiratory medications.\n\nConclusion\nTiotropium Bromide and Formoterol Fumarate Inhaler is a highly effective combination treatment for patients suffering from COPD and asthma. By providing both rapid symptom relief and long-term airway maintenance, it helps patients breathe more easily, reduces the frequency of exacerbations, and improves overall quality of life. Proper usage, adherence to prescribed dosage, and monitoring for side effects are essential for achieving the best results. For anyone managing chronic respiratory conditions, this inhaler represents a reliable and convenient treatment option under medical guidance.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2196, "imageuri": "https://productimages.withfloats.com/actual/690b41c1d25e5639c9089541.png", "tileimageuri": "https://productimages.withfloats.com/tile/690b41c1d25e5639c9089541.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-05T12:23:27.485Z", "updatedon": "2026-03-14T08:50:22.16Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tiotropium-bromide-and-formoterol-fumarate-inhaler/2196", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TIOTROPIN F", "category": "ASTHMA RANGE", "tags": [ "Tiotropium Bromide and Formoterol Fumarate Inhaler", "Chronic Obstructive Pulmonary Disease (COPD) and asthma.", "Chronic Obstructive Pulmonary Disease (COPD) and asthma" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666be30aa20cb42140743ca6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RISPERITIME PLUS ", "description": "RISPERITIME PLUS \nRisperidone (2mg), Trihexyphenidyl (2mg)\nIntroduction:\n\nRisperitime Plus is a combination medication containing Risperidone (2mg) and Trihexyphenidyl (2mg), designed to offer comprehensive management for psychiatric disorders. This dual-action formula targets both the symptoms of mental health conditions and the side effects associated with antipsychotic treatments, providing a balanced approach to patient care.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nRisperidone: As a second-generation antipsychotic, Risperidone effectively antagonizes dopamine and serotonin receptors. This action helps mitigate symptoms such as hallucinations, delusions, and disorganized thinking, common in schizophrenia and bipolar disorder.\nMood Stabilization:\n\nRisperidone also aids in stabilizing mood swings in bipolar disorder, reducing the severity of manic episodes and preventing depressive relapses. This contributes to overall emotional balance and improved quality of life.\nManagement of Side Effects:\n\nTrihexyphenidyl: An anticholinergic agent, Trihexyphenidyl is included to manage extrapyramidal symptoms (EPS) caused by antipsychotic medications. It helps alleviate symptoms such as muscle stiffness, tremors, and restlessness, which are side effects of Risperidone and other antipsychotics.\nBehavioral and Cognitive Benefits:\n\nRisperitime Plus addresses behavioral issues such as aggression, agitation, and irritability, particularly in conditions like autism spectrum disorders and dementia-related behavioral disturbances.\nIt may also offer cognitive enhancements, improving attention, executive function, and overall cognitive performance in certain patients.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Risperitime Plus is 2mg Risperidone and 2mg Trihexyphenidyl taken orally once daily. Dosage adjustments should be based on clinical response and tolerability.\nAdministration Instructions:\nSwallow the tablets whole with water, with or without food. Consistency in dosing time each day is important for maintaining therapeutic levels.\nTitration and Maintenance:\nHealthcare providers may adjust the dosage gradually to achieve optimal symptom control while minimizing side effects. Maintenance doses are personalized to each patient's needs and treatment goals.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW ", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "EPS", "food", "life", "EMAIL", "needs", "water", "dosing", "product", "quality", "tablets", "tremors", "dopamine", "severity", "patients", "delusions", "attention", "Titration", "agitation", "aggression", "mood swings", "Consistency", "information", "restlessness", "irritability", "Introduction", "tolerability", "sterispharma", "sterisonline", "patient care", "side effects", "Key Features", "schizophrenia", "starting dose", "CALL/WHATSAPP", "manic episodes", "hallucinations", "Initial Dosage", "2mg Risperidone", "treatment goals", "RISPERITIME PLUS", "muscle stiffness", "bipolar disorder", "Maintenance doses", "clinical response", "behavioral issues", "balanced approach", "Dosage adjustments", "executive function", "therapeutic levels", "Cognitive Benefits", "Mood Stabilization", "dual-action formula", "serotonin receptors", "depressive relapses", "2mg Trihexyphenidyl", "other antipsychotics", "Healthcare providers", "disorganized thinking", "anticholinergic agent", "psychiatric disorders", "combination medication", "Antipsychotic Efficacy", "cognitive enhancements", "extrapyramidal symptoms", "optimal symptom control", "antipsychotic treatments", "comprehensive management", "mental health conditions", "autism spectrum disorders", "antipsychotic medications", "overall emotional balance", "Administration Instructions", "overall cognitive performance", "second-generation antipsychotic", "dementia-related behavioral disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1892, "imageuri": "https://productimages.withfloats.com/actual/666be30d117f82c50b0c8762.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/666be30d117f82c50b0c8762.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:28:26.525Z", "updatedon": "2026-03-12T11:42:56.949Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//risperitime-plus-/1892", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RISPERITIME PLUS ", "category": "NEUROLOGY RANGE", "tags": [ "Trihexyphenidyl (2mg)", "Risperidone (2mg)", "RISPERITIME PLUS", "", "risdone plus side effects", "risdone plus dosage", "risperidone and trihexyphenidyl tablets uses in hi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661520ed91d281c30c74bbb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "R/C TIOTROPIN 3D ", "description": "R/C TIOTROPIN 3D \nCiclesonide (400mcg), Formoterol (12mcg), Tiotropium (18mcg)\nR/C TIOTROPIN 3D is a powerful combination medication designed to provide comprehensive relief for respiratory conditions. With Ciclesonide at 400mcg, Formoterol at 12mcg, and Tiotropium at 18mcg, this formulation targets multiple aspects of respiratory health. Ciclesonide, a potent corticosteroid, helps reduce inflammation in the airways, easing breathing difficulties. Formoterol, a long-acting beta agonist, works to relax the muscles around the airways, facilitating better airflow. Tiotropium, an anticholinergic agent, further opens up the air passages, making breathing smoother and more comfortable. Together, these components create a synergistic effect, providing effective relief for individuals with respiratory conditions.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: https://www.sterisonline.com/product/r-c-tiotropin-3d-133719\n\n\n\n\n\n\n\n\n", "price": 340.0, "discountamount": 102.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "Email", "18mcg", "12mcg", "400mcg", "airflow", "muscles", "airways", "product", "WhatsApp", "Formoterol", "Tiotropium", "components", "information", "Ciclesonide", "individuals", "formulation", "air passages", "sterispharma", "inflammation", "sterisonline", "multiple aspects", "R/C TIOTROPIN 3D", "effective relief", "synergistic effect", "respiratory health", "acting beta agonist", "comprehensive relief", "anticholinergic agent", "potent corticosteroid", "respiratory conditions", "breathing difficulties", "powerful combination medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1401, "imageuri": "https://productimages.withfloats.com/actual/666152106030c166b1a88356.png", "tileimageuri": "https://productimages.withfloats.com/tile/666152106030c166b1a88356.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:07:10.216Z", "updatedon": "2026-03-14T08:30:24.358Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//r-c-tiotropin-3d-/1401", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "R/C TIOTROPIN 3D ", "category": "ASTHMARANGE", "tags": [ "R/C TIOTROPIN 3D", "Ciclesonide (400mcg),", "Formoterol (12mcg)", "Tiotropium (18mcg)", "Formoterol inhaler", "Formoterol fumarate", "Formoterol fumarate and budesonide inhaler", "Formoterol side effects", "Formoterol Easyhaler 12 mcg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a7722af7f45a0190eb37920", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tolperisone Hydrochloride & Paracetamol Tablets", "description": "TOPERITIME P 150/325: Dual-Action Relief for Musculoskeletal Pain and Spasms\nTOPERITIME P 150/325 is a prescription combination therapy formulated to treat acute musculoskeletal discomfort, muscle stiffness, and associated inflammatory pain. By uniting a centrally acting muscle relaxant with a proven analgesic, this film-coated tablet addresses both the neurological and physical aspects of muscle strain, restoring movement and facilitating recovery.\n\nActive Ingredients\nEach film-coated tablet contains:\n\nTolperisone Hydrochloride (150 mg): A muscle relaxant targeting involuntary contractions within the central nervous system.\n\nParacetamol (325 mg): A widely recognized analgesic and antipyretic agent that blocks pain signal transmission.\n\nAvailable in blister packaging and dispensed strictly under a licensed physician's order.\n\nTherapeutic Mechanism\nPainful muscle conditions often create a feedback loop where localized pain triggers involuntary spasms, which in turn exacerbate the pain. TOPERITIME P 150/325 disrupts this cycle through a two-pronged mechanism:\n\nNeuromuscular Regulation: Tolperisone Hydrochloride acts on the spinal cord and brainstem reflexes to inhibit hyperactive nerve impulses driving muscle tension. Unlike traditional skeletal muscle relaxants, it achieves this with minimal central nervous system depression, significantly reducing the likelihood of heavy sedation.\n\nNociceptive Blocking: Paracetamol inhibits prostaglandin synthesis within the central nervous system, raising the body's overall pain threshold and attenuating pain signals originating from injured tissues.\n\nBy simultaneously relaxing tight muscle fibers and dampening pain sensation, the formulation provides comprehensive symptomatic relief.\n\nClinical Indications\nHealthcare professionals may prescribe TOPERITIME P 150/325 for various acute and subacute conditions characterized by pain and hypertonia, including:\n\nAcute muscle spasms and athletic injuries\n\nAcute or chronic lower back pain (lumbago)\n\nCervical spine discomfort and stiff neck\n\nCervical and lumbar spondylosis\n\nFrozen shoulder (adhesive capsulitis)\n\nPost-operative or post-traumatic muscle recovery\n\nGeneralized connective tissue or orthopedic pain\n\nKey Clinical Features\nBalanced Dual Action: Simultaneously targets involuntary contractions and pain sensation.\n\nLow-Sedation Profile: Tolperisone allows patients to maintain daily function without severe daytime drowsiness typical of older relaxants.\n\nEnhanced Mobility: Reduces joint and tissue stiffness, enabling better engagement in physical rehabilitation.\n\nStreamlined Regimen: Combines two therapeutic agents into a single convenient dosage form.\n\nUsage Guidelines\nThis medication must be taken strictly in accordance with a medical prescription.\n\nAdministration: Swallow the tablet whole with water. Do not crush, chew, or split the film-coated tablet.\n\nTiming: Take immediately after a meal to reduce potential gastrointestinal upset, unless directed otherwise by a doctor.\n\nCompliance: Complete the full course prescribed by your physician, and do not alter the recommended dosage.\n\nPotential Side Effects\nWhile generally well-tolerated, some individuals may experience mild side effects, including:\n\nGastrointestinal distress or mild nausea\n\nTransient dizziness or lightheadedness\n\nHeadaches\n\nGeneral fatigue or muscular weakness\n\nRare: Hypersensitivity reactions or cutaneous skin rashes (discontinue use and consult a physician immediately if severe symptoms appear).\n\nSafety Precautions and Considerations\nConsult a medical practitioner prior to initiating treatment if any of the following apply:\n\nPre-existing hepatic (liver) or renal (kidney) impairment\n\nKnown hypersensitivity to Tolperisone, Paracetamol, or related compounds\n\nPregnancy, plans for pregnancy, or active breastfeeding\n\nHistory of chronic alcohol dependency (due to increased liver sensitivity with Paracetamol)\n\nConcurrent use of other medications, particularly other products containing Paracetamol or central nervous system depressants\n\nStorage and Handling\nStore in a cool, dry area below 25°C (77°F).\n\nProtect from direct light, heat, and moisture.\n\nKeep strictly out of reach of children and pets.\n\nCheck the packaging expiration date before administration.\n\nFrequently Asked Questions\nWhat primary conditions does TOPERITIME P 150/325 treat?\n\nIt is indicated for short-term relief from acute musculoskeletal pain, muscle spasms, neck strains, backaches, and related orthopedic disorders.\n\nWhy is Tolperisone combined with Paracetamol?\n\nTolperisone eases muscle tightness at the neurological level, while Paracetamol lowers overall pain perception, creating a synergistic effect that addresses both spasm and pain together.\n\nWill this medication cause severe drowsiness?\n\nTolperisone is specifically designed to exert less sedating activity compared to older muscle relaxants. However, individual sensitivity varies, so caution is advised when driving or operating machinery until individual tolerance is established.\n\nIs TOPERITIME P 150/325 available over the counter?\n\nNo. It requires a valid medical prescription and direct supervision by a registered healthcare professional.", "price": 95.0, "discountamount": 29.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2493, "imageuri": "https://productimages.withfloats.com/actual/6a7722b0ed25653efa18364e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a7722b0ed25653efa18364e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-08T12:35:59.075Z", "updatedon": "2026-08-08T12:35:59.075Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-paracetamol-tablets/2493", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TOPERITIME P 150/325", "category": "ORTHOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dec4d7747964c2eea9a0f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metoprolol Succinate & Hydrochlorthiazide Extended Release Tablets", "description": "METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing.\n\nManufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels.\n\nComposition\n\nBrand Name: METAPROLATE H 50/12.5\n\nGeneric Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets\n\nEach Extended Release Tablet Contains:\n\nMetoprolol Succinate Extended Release – 50 mg\nHydrochlorothiazide – 12.5 mg\n\nDosage Form: Extended Release Tablets\n\nTherapeutic Category: Antihypertensive Medication\n\nWhat is METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management.\n\nMetoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure.\n\nTogether, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice.\n\nUses of METAPROLATE H 50/12.5\n\nHealthcare professionals may prescribe METAPROLATE H 50/12.5 for:\n\nManagement of essential hypertension\nPatients requiring combination antihypertensive therapy\nLong-term maintenance of healthy blood pressure levels\nReducing cardiovascular risks associated with uncontrolled hypertension\nSupporting comprehensive blood pressure management alongside lifestyle modifications\n\nThis medicine should always be used under the supervision of a qualified healthcare professional.\n\nBenefits of METAPROLATE H 50/12.5\nDual-Action Blood Pressure Control\n\nThe combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction.\n\nSustained Drug Release\n\nThe extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control.\n\nConvenient Once-Daily Administration\n\nA single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy.\n\nSupports Cardiovascular Health\n\nMaintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time.\n\nManufactured to High Quality Standards\n\nEvery batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency.\n\nHow METAPROLATE H 50/12.5 Works\n\nThe effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients.\n\nMetoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps:\n\nSlow the heart rate\nReduce the force of cardiac contractions\nDecrease oxygen demand by the heart\nLower blood pressure\n\nHydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps:\n\nReduce circulating blood volume\nMinimize fluid retention\nLower blood pressure\nImprove overall cardiovascular function\n\nTogether, these mechanisms contribute to effective and sustained blood pressure management.\n\nDosage and Administration\n\nTake METAPROLATE H 50/12.5 exactly as prescribed by your physician.\n\nGeneral recommendations include:\n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the extended-release tablet whole with water.\nDo not crush, chew, or split the tablet unless specifically instructed.\nIt may be taken with or without food according to your doctor's advice.\nTake the medication at the same time each day to maintain consistent therapeutic levels.\nContinue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise.\nPossible Side Effects\n\nAs with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well.\n\nCommonly reported side effects include:\n\nDizziness\nTiredness or fatigue\nSlow heartbeat\nHeadache\nIncreased urination\nNausea\nLow blood pressure\nChanges in electrolyte levels\n\nSeek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms.\n\nConsult your healthcare provider if any side effect persists or becomes troublesome.\n\nPrecautions and Warnings\n\nBefore starting METAPROLATE H 50/12.5, inform your healthcare provider if you have:\n\nHeart rhythm abnormalities\nHeart failure\nAsthma or chronic respiratory disorders\nDiabetes mellitus\nKidney or liver impairment\nGout\nElectrolyte imbalance\nThyroid disorders\nAllergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product\n\nRegular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from excessive heat, moisture, and direct sunlight.\nKeep the tablets in their original packaging until use.\nStore at the temperature indicated on the product label.\nKeep out of the reach of children.\nWhy Choose METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care.\n\nKey Advantages\n\nExtended-release formulation for sustained therapeutic action\nCombination of two proven antihypertensive medicines\nConvenient once-daily dosing\nHigh-quality manufacturing with strict quality assurance\nReliable efficacy and consistent product performance\nSuitable for long-term hypertension management under medical supervision\nFrequently Asked Questions (FAQs)\nWhat is METAPROLATE H 50/12.5 prescribed for?\n\nIt is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy.\n\nHow does the extended-release formulation benefit patients?\n\nThe extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control.\n\nCan I discontinue METAPROLATE H 50/12.5 on my own?\n\nNo. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment.\n\nCan this medicine be used with other antihypertensive medications?\n\nYour doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals.\n\nHow long should treatment continue?\n\nHypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.", "price": 248.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2488, "imageuri": "https://productimages.withfloats.com/actual/6a6dec4fc0246085c8f72513.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6dec4fc0246085c8f72513.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T12:53:33.409Z", "updatedon": "2026-08-01T12:53:33.409Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metoprolol-succinate-hydrochlorthiazide-extended-release-tablets/2488", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE H 50/12.5", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a685f3a5315456e18559082", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Acebrophylline and Erdosteine Tablets", "description": "Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.\n\nAt [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.\n\nComposition\nEach film-coated tablet typically contains:\n\nAcebrophylline – 200 mg\nErdosteine – 300 mg\nComposition can be customized based on customer requirements and regulatory approvals.\n\nHow Acebrophylline and Erdosteine Tablets Work\nThe combination provides comprehensive respiratory support through complementary mechanisms.\n\nAcebrophylline\nAcebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.\n\nErdosteine\nErdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.\n\nTogether, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.\n\nKey Benefits of Acebrophylline and Erdosteine Tablets\nHelps improve breathing by relaxing bronchial muscles\nEffectively reduces thick mucus accumulation\nSupports easier mucus clearance from the lungs\nReduces chronic cough and chest congestion\nHelps manage COPD and chronic bronchitis symptoms\nProvides antioxidant protection to respiratory tissues\nImproves oxygen exchange and lung function\nEnhances quality of life in patients with chronic respiratory disorders\nSuitable for long-term respiratory disease management under medical supervision\nMedical Uses of Acebrophylline and Erdosteine Tablets\nHealthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:\n\nChronic Obstructive Pulmonary Disease (COPD)\nChronic Bronchitis\nBronchial Asthma\nRespiratory Tract Infections with Excessive Mucus\nChronic Productive Cough\nAirway Inflammation\nBronchiectasis\nSmoking-related Respiratory Conditions\nThese tablets should always be used under the supervision of a qualified healthcare professional.\n\nAdvantages of the Acebrophylline and Erdosteine Combination\nThe combination therapy offers several clinical advantages over single-drug treatment.\n\nDual Mechanism of Action\nIt simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.\n\nImproved Lung Function\nPatients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.\n\nReduced Frequency of Exacerbations\nRegular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.\n\nBetter Patient Compliance\nA fixed-dose combination simplifies treatment by reducing the need for multiple medications.\n\nRecommended Dosage\nThe dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.\n\nGeneral recommendations include:\n\nTake the tablet after meals with water.\nSwallow whole without crushing or chewing.\nFollow the prescribed duration of therapy.\nDo not exceed the recommended dose.\nPossible Side Effects\nLike all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nHeadache\nDizziness\nMild diarrhea\nDry mouth\nGastric irritation\nSeek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.\n\nPrecautions\nBefore using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:\n\nLiver disease\nKidney impairment\nGastric ulcer\nHeart disease\nPregnancy or breastfeeding\nKnown allergy to methylxanthines or Erdosteine\nAvoid self-medication and always follow professional medical advice.\n\nStorage Instructions\nStore below 25°C in a cool and dry place.\nProtect from direct sunlight and moisture.\nKeep out of reach of children.\nDo not use after the expiry date.\nWhy Choose Our Acebrophylline and Erdosteine Tablets?\nWe are committed to delivering pharmaceutical products that meet international quality standards.\n\nOur advantages include:\n\nWHO-GMP Certified Manufacturing\nISO Certified Production Facilities\nStringent Quality Control\nDCGI-Compliant Manufacturing\nCompetitive Pricing\nBulk Supply Capability\nThird-Party Manufacturing Services\nPrivate Label Packaging\nTimely Global Deliveries\nCustom Packaging Solutions\nWe serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.\n\nFrequently Asked Questions (FAQs)\n1. What are Acebrophylline and Erdosteine Tablets used for?\nAcebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.\n\n2. How do Acebrophylline and Erdosteine Tablets work?\nAcebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.\n\n3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?\nYes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.\n\n4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?\nThey may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.\n\n5. Can these tablets be used for asthma?\nYes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.\n\n6. Do Acebrophylline and Erdosteine Tablets have side effects?\nMost side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.\n\n7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?\nThey are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.\n\n8. Can smokers use Acebrophylline and Erdosteine Tablets?\nYes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.\n\n9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?\nYes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.\n\n10. Why buy Acebrophylline and Erdosteine Tablets from us?\nOur products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.\n\nThis version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2487, "imageuri": "https://productimages.withfloats.com/actual/6a685f3db435445dbdc3d469.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:50:18.551Z", "updatedon": "2026-07-28T07:50:18.551Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//acebrophylline-and-erdosteine-tablets/2487", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIPHYLLIN ERDO", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }